A. Marie Blackmore

1 Introduction Cerebral palsy-Hōkai Nukurang (CP) is a non-progressive neurodevelopmental condition with variable impact on all movements and posture. In developed countries, the prevalence of CP is 1.6 per 1000 live births [1], meaning there are approximately 2073 young people (0–19 years) currently living with CP in Aotearoa New Zealand (NZ) [2].

Supporting Information Filename Description dmcn16262-sup-0001-AppendixS1.pdfPDF document, 1.5 MB Appendix S1: Respiratory questionnaire for parents of children with cerebral palsy. dmcn16262-sup-0002-TableS1.docxWord 2007 document , 22.3 KB Table S1: Antibiotics chosen to represent treatment for respiratory illness by chemical formulation name.

Statistical analysis Continuous data are presented as medians, interquartile ranges (IQR), and ranges as data were skewed in distribution. To determine the total costs for each clinical area, bed-days for same-day, subacute, overnight, and ICU were aggregated and multiplied by average costs per day for each bed-day type. The clinical areas were then ranked from highest to lowest for LOS and total cost.